Pharmaceutical glass manufacturer Gerresheimer is to expand its glass vial production at its Wertheim, Germany manufacturing facility.
The company said it was to invest in production in Wertheim to increase vials capacity by 150 million vials per year. It also plans to create 70 new jobs for this purpose.
Until now, the company had served European demand for vials from its plants in Boleslawiec, Poland and Chalon, France.
Gerresheimer CEO Dietmar Siemssen, said: "We already produce almost a third of the world's glass vials worldwide.
"With the expansion of our global capacities we are consistently implementing our growth strategy.
The German Federal Ministry for Economic Affairs and Climate Action is supporting the investment in Wertheim.
By expanding its production capacity in Wertheim, Gerresheimer is making an important contribution to improving the supply of glass vials to European vaccine manufacturers, among other things.
The technology used in Wertheim enables vials to be produced in GX-Elite quality.
Gerresheimer has substantially increased its production capacities for vials by 50% compared to pre pandemic levels.
In the long term, Gerresheimer's management expects an increasing demand for drugs which have to be injected - and therefore a higher demand for vials.
The global pandemic has highlighted the importance of a reliable and high-quality supply of injection solutions.
